John A. Fry - Nov 28, 2022 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Role
Director
Signature
/s/ Paul Sekhri, as Attorney-in-Fact
Stock symbol
VTVT
Transactions as of
Nov 28, 2022
Transactions value $
$50,742
Form type
4
Date filed
11/30/2022, 08:45 PM
Previous filing
Nov 28, 2022
Next filing
Feb 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTVT Class A common stock Purchase $17K +20.5K $0.83 20.5K Nov 28, 2022 Direct F1
transaction VTVT Class A common stock Purchase $33.8K +40.5K +197% $0.83 61K Nov 29, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.805 to $0.8487, inclusive. The reporting person undertakes to provide to vTv Therapeutics Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote to this Form 4.
F2 The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.81 to $0.849, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote to this Form 4.